Allspring Global Investments
ANIP icon

Allspring Global Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Allspring Global Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
12,177
+1,920
+19% +$154K ﹤0.01% 1232
2026
Q1 		$779K Buy
10,257
+1,062
+12% +$82.9K ﹤0.01% 1254
2025
Q4 		$721K Buy
9,195
+804
+10% +$69.6K ﹤0.01% 1257
2025
Q3 		$757K Sell
8,391
-70
-0.8% -$5.71K ﹤0.01% 1234
2025
Q2 		$552K Sell
8,461
-488
-5% -$31.8K ﹤0.01% 1312
2025
Q1 		$599K Buy
8,949
+3,112
+53% +$186K ﹤0.01% 1395
2024
Q4 		$323K Sell
5,837
-15,894
-73% -$913K ﹤0.01% 1562
2024
Q3 		$1.3M Sell
21,731
-1,020
-4% -$62.2K ﹤0.01% 1266
2024
Q2 		$1.45M Buy
22,751
+1,474
+7% +$95.7K ﹤0.01% 1248
2024
Q1 		$1.47M Buy
21,277
+15,790
+288% +$953K ﹤0.01% 1269
2023
Q4 		$303K Buy
5,487
+2,107
+62% +$116K ﹤0.01% 1607
2023
Q3 		$196K Buy
3,380
+989
+41% +$57.1K ﹤0.01% 1767
2023
Q2 		$129K Buy
+2,391
New +$106K ﹤0.01% 1966
2023
Q1 		– Sell
-72
Closed -$2.9K – 2775
2022
Q4 		$2.9K Sell
72
-2
-3% -$75 ﹤0.01% 2827
2022
Q3 		$2K Sell
74
-567
-88% -$19.4K ﹤0.01% 2820
2022
Q2 		$19K Sell
641
-3,897
-86% -$112K ﹤0.01% 2492
2022
Q1 		$127K Buy
4,538
+279
+7% +$10.4K ﹤0.01% 2698
2021
Q4 		$196K Buy
+4,259
New +$183K ﹤0.01% 2639

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's ANIP Position: Q2 2026 in Review

Allspring Global Investments increased its ANI Pharmaceuticals (ANIP) stake by 19% in Q2 2026, buying an estimated $154K and bringing the position to 12,177 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

Allspring Global Investments first reported a position in ANIP in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.47M in Q1 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Allspring Global Investments held 12,177 shares of ANI Pharmaceuticals worth $1.01M as of Q2 2026.
  • Allspring Global Investments bought 1,920 ANI Pharmaceuticals shares in Q2 2026, an estimated $154K.
  • ANI Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1232 holding.
  • Allspring Global Investments first reported a position in ANI Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's ANI Pharmaceuticals position peaked at $1.47M in Q1 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.